Safety and Efficacy of Six Months' Open Label Extension Post-RCT Using the Novel Cathepsin K Inhibitor MIV-711 in Patients With Knee Osteoarthritis

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.564

Related search